Palatin Technologies Stock Price

-0.0052 (-0.91%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.0052 -0.91% 0.565 0.00 0.00 0.00 0.5702 08:58:02
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10 24,813 $ 0.5657655 $ 14,038 3,611,903 0.331 - 1.09
Last Trade Time Type Quantity Stock Price Currency
08:23:12 9 $ 0.57 USD

Palatin Technologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 129.53M 229.26M 210.92M $ 60.30M $ - 0.16 3.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
11.07M $ - 0.00% - -

more financials information »

Palatin Technologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.610.6240.56010.57752491,097,564-0.045-7.38%
1 Month0.530.700.49260.57715291,969,4350.0356.6%
3 Months0.46230.770.4350.56508272,840,0570.102722.22%
6 Months0.660.770.3310.53314872,118,511-0.095-14.39%
1 Year0.921.090.3310.63548071,600,257-0.355-38.59%
3 Years0.422.210.3310.90433121,737,4400.14534.52%
5 Years0.95452.210.28510.78927381,528,044-0.3895-40.81%

Palatin Technologies Description

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Your Recent History
Palatin Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.